Cargando…
Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment
The development of novel therapies for brain metastases is an unmet need. Brain metastases may have unique molecular features that could be explored as therapeutic targets. A better understanding of the drug sensitivity of live cells coupled to molecular analyses will lead to a rational prioritizati...
Autores principales: | Morikawa, Aki, Li, Jinju, Ulintz, Peter, Cheng, Xu, Apfel, Athena, Robinson, Dan, Hopkins, Alex, Kumar-Sinha, Chandan, Wu, Yi-Mi, Serhan, Habib, Verbal, Kait, Thomas, Dafydd, Hayes, Daniel F., Chinnaiyan, Arul M., Baladandayuthapani, Veerabhadran, Heth, Jason, Soellner, Matthew B., Merajver, Sofia D., Merrill, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284082/ https://www.ncbi.nlm.nih.gov/pubmed/37377606 http://dx.doi.org/10.1158/2767-9764.CRC-22-0492 |
Ejemplares similares
-
IMPACT the Brain: A Team-Based Approach to Management of Metastatic Breast Cancer With CNS Metastases
por: Fleege, Nicole M. Grogan, et al.
Publicado: (2023) -
OTHR-13. IMPACT the brain: improving metastatic breast cancer patient access to coordinated treatment
por: Grogan, Nicole, et al.
Publicado: (2021) -
Landscape of gene fusions in epithelial cancers: seq and ye shall find
por: Kumar-Sinha, Chandan, et al.
Publicado: (2015) -
Bayesian Disease Classification Using Copy Number Data
por: Guha, Subharup, et al.
Publicado: (2014) -
BaySyn: Bayesian Evidence Synthesis for Multi-system Multiomic Integration
por: Bhattacharyya, Rupam, et al.
Publicado: (2023)